Global sourcing of pharmaceutical APIs, excipients and specialty raw materials. LC-backed international trade finance bridging leading manufacturers to India's pan-national distribution network.
Finadore Impex LLC operates from IFZA, Dubai as the international arm of the Finadore Group — a dual-entity conglomerate spanning six verticals. Our pharmaceutical division specialises in sourcing GMP-certified APIs and raw materials from leading Chinese and European manufacturers, channelling them through LC-backed trade finance structures into India's pan-national pharmaceutical supply chain.
Azithromycin, Amoxicillin, Ciprofloxacin, Cefixime, Metronidazole and 20+ broad-spectrum antibiotic active pharmaceutical ingredients sourced from WHO-GMP certified facilities.
Atorvastatin, Metformin, Amlodipine, Losartan, Rosuvastatin — life-critical APIs for cardiovascular and metabolic disorders with full regulatory dossiers.
Specialty oncology APIs including Imatinib, Capecitabine, Gefitinib and targeted therapy molecules sourced from accredited manufacturers under strict chain-of-custody protocols.
Pharmaceutical-grade excipients including HPMC, PVP, Microcrystalline Cellulose, Lactose Monohydrate, Magnesium Stearate and specialty coating polymers.
Central nervous system APIs including Gabapentin, Pregabalin, Clonazepam precursors and antidepressant actives with NDPS-compliant documentation for Indian regulatory filings.
End-to-end custom molecule sourcing with full dossier preparation — CoA, MSDS, DMF extracts, CEP certificates and stability data — tailored to your CDSCO or export market requirements.
Submit your API or raw material requirement with quantity, specification and target market. Our team responds within 24 hours.
We identify the best-fit GMP-certified manufacturer from our global network, presenting COA, audit reports and pricing comparison.
Finadore structures the LC through empanelled Indian banks — buyer's CC/OD limits or Usance LC — securing the transaction for all parties.
Full documentation management — CDSCO import licence, customs clearance, CHA coordination — with delivery to your warehouse or CFA.
Headquartered in IFZA Free Zone, Dubai, Finadore Impex LLC bridges pharmaceutical manufacturing hubs in China, India and Europe with buyer networks across South Asia, the Middle East and Africa. Our dual-entity structure — Dubai trading arm and Mumbai holding — enables seamless cross-border LC transactions with optimal tax efficiency.
Every molecule we supply meets the gold standard of pharmaceutical regulatory compliance. Our supplier qualification framework covers documentation, on-site audit reports and third-party laboratory verification before any shipment is executed.
| Product Category | MOQ | Lead Time | Incoterms | Certification |
|---|---|---|---|---|
| Antibiotic APIs | 25 KG | 21–28 days | CIF / FOB / CFR | WHO-GMP · US-FDA |
| Cardiovascular & Metabolic | 50 KG | 21–35 days | CIF / FOB | WHO-GMP · EU-GMP |
| Oncology APIs | 1 KG | 28–45 days | CIF Nhava Sheva | WHO-GMP · US-FDA |
| Excipients & Polymers | 100 KG | 14–21 days | CIF / FOB / EXW | IP / BP / USP / NF |
| CNS & Neurological | 10 KG | 25–35 days | CIF / FOB | WHO-GMP · NDPS |
| Custom Sourcing | Negotiable | 35–60 days | As agreed | Per buyer spec |
Whether you are a pharmaceutical manufacturer, formulator or distributor seeking a trusted API sourcing partner — or a supplier looking to access India's market through LC-backed trade structures — we welcome your enquiry.
By submitting, your default email client will open with a pre-composed enquiry
addressed to info@finadoreimpex.com — simply press Send.
Finadore Impex LLC is the international trading arm of the Finadore Group — a dual-entity conglomerate headquartered across Mumbai, India and Dubai, UAE, operating six high-growth verticals with combined revenue targets exceeding USD 5 billion across its joint venture portfolio.
We monitor CDSCO circulars, FSSAI updates, DGFT trade policy changes and WHO prequalification notices — keeping our partners ahead of regulatory shifts that affect API sourcing, import documentation and distribution.
Subscribe to Updates →Kameswar Rao is the Chairman & Managing Director of Finadore Group — a dual-entity international trade finance and commodity conglomerate operating across six verticals including pharmaceutical raw materials, agro-commodities, energy, EPC, and business aviation. An investment banker and financial engineer with a BSc in Mathematics, he architects complex LC-backed trade structures that bridge global pharmaceutical manufacturers with Indian buyers.